Difference between revisions of "Team:Shanghai Metro Utd"
| Line 90: | Line 90: | ||
<div class="home-content"> | <div class="home-content"> | ||
<div class="top-banner"> | <div class="top-banner"> | ||
| − | <img src="https://static.igem.org/mediawiki/2021/9/91/T-- | + | <img src="https://static.igem.org/mediawiki/2021/9/91/T--Shanghai_Metro_Utd--top.gif" /> |
</div> | </div> | ||
<div class="swiper-container top-swiper-container group-photo"> | <div class="swiper-container top-swiper-container group-photo"> | ||
<div class="swiper-wrapper"> | <div class="swiper-wrapper"> | ||
<div class="swiper-slide"> | <div class="swiper-slide"> | ||
| − | <img src="https://static.igem.org/mediawiki/2021/2/20/T-- | + | <img src="https://static.igem.org/mediawiki/2021/2/20/T--Shanghai_Metro_Utd--homepage01.png" /> |
</div> | </div> | ||
<div class="swiper-slide"> | <div class="swiper-slide"> | ||
| − | <img src="https://static.igem.org/mediawiki/2021/f/fa/T-- | + | <img src="https://static.igem.org/mediawiki/2021/f/fa/T--Shanghai_Metro_Utd--homepage02.png" /> |
</div> | </div> | ||
<div class="swiper-slide"> | <div class="swiper-slide"> | ||
| − | <img src="https://static.igem.org/mediawiki/2021/f/fe/T-- | + | <img src="https://static.igem.org/mediawiki/2021/f/fe/T--Shanghai_Metro_Utd--homepage03.png" /> |
</div> | </div> | ||
</div> | </div> | ||
| Line 121: | Line 121: | ||
</div> | </div> | ||
<video width="100%" height="769" controls class="home-video"> | <video width="100%" height="769" controls class="home-video"> | ||
| − | <source src="https://static.igem.org/mediawiki/2021/9/93/T-- | + | <source src="https://static.igem.org/mediawiki/2021/9/93/T--Shanghai_Metro_Utd--video.mp4" type="video/mp4"> |
</video> | </video> | ||
</div> | </div> | ||
Revision as of 15:18, 26 September 2021
ABSTRACT
Parkinson’s disease (PD) is an inflammatory brain disease that affects 20 million people worldwide and the incidence is expected to rise. However, current medical treatment is not optimal, and thus an effective treatment is very much needed. Surprisingly, we discovered that a specific protein called Angiogenin is reported as a potential therapeutic target to neurodegenerative disease given. In this project, our team Healers on Vessels aim to construct a recombinant E. coli by biomedical engineering that can continuously synthesize functional ANG protein, which could possibly serve as an in vitro method to massive produce ANG for clinical use.